Posted by Michael Wonder on 20 Jan 2020
New science strategy prepares regulatory scientists for the future
20 January 2020 - The Health Products Regulation Group in the Department of Health has published a new regulatory science strategy to ensure regulatory scientists are prepared for future challenges and emerging technologies.
The strategy sets the direction over the next five-years for scientists in the Therapeutic Goods Administration, which regulates medicines and medical devices, and the Office of Drug Control, which regulates the import, export and manufacture of controlled drugs as well as the cultivation of medicinal cannabis.
